Cargando…
A 12-week multidomain intervention versus active control to reduce risk of Alzheimer’s disease: study protocol for a randomized controlled trial
BACKGROUND: Disappointing results from clinical trials of disease-modifying interventions for Alzheimer’s dementia (AD), along with reliable identification of modifiable risk factors in mid life from epidemiological studies, have contributed to calls to invest in risk-reduction interventions. It is...
Autores principales: | Anstey, Kaarin J, Bahar-Fuchs, Alex, Herath, Pushpani, Rebok, George W, Cherbuin, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3598396/ https://www.ncbi.nlm.nih.gov/pubmed/23442574 http://dx.doi.org/10.1186/1745-6215-14-60 |
Ejemplares similares
-
Body brain life: A randomized controlled trial of an online dementia risk reduction intervention in middle-aged adults at risk of Alzheimer's disease
por: Anstey, Kaarin J., et al.
Publicado: (2015) -
Development of a New Method for Assessing Global Risk of Alzheimer’s Disease for Use in Population Health Approaches to Prevention
por: Anstey, Kaarin J., et al.
Publicado: (2013) -
The Effect of Diabetes Medication on Cognitive Function: Evidence from the PATH Through Life Study
por: Herath, Pushpani M., et al.
Publicado: (2016) -
A Self-Report Risk Index to Predict Occurrence of Dementia in Three Independent Cohorts of Older Adults: The ANU-ADRI
por: Anstey, Kaarin J., et al.
Publicado: (2014) -
Body, Brain, Life for Cognitive Decline (BBL-CD): protocol for a multidomain dementia risk reduction randomized controlled trial for subjective cognitive decline and mild cognitive impairment
por: McMaster, Mitchell, et al.
Publicado: (2018)